TGIA
MRNA icon

Torrey Growth & Income Advisors’s Moderna MRNA Stock Holding History

Torrey Growth & Income Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,350
Closed -$461K – 117
2026
Q1 		$461K Sell
9,350
-100
-1% -$4.67K 0.19% 65
2025
Q4 		$279K Buy
+9,450
New +$257K 0.1% 90

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Torrey Growth & Income Advisors's MRNA Position: Q2 2026 in Review

Torrey Growth & Income Advisors sold out of Moderna (MRNA) in Q2 2026, closing a stake of 9,350 shares — an estimated $461K sold.

Torrey Growth & Income Advisors first reported a position in MRNA in Q4 2025 and held it in 2 quarters. The position peaked at $461K in Q1 2026. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Torrey Growth & Income Advisors reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Torrey Growth & Income Advisors sold 9,350 Moderna shares in Q2 2026, an estimated $461K.
  • Torrey Growth & Income Advisors first reported a position in Moderna in Q4 2025 and held it in 2 quarters.
  • Torrey Growth & Income Advisors's Moderna position peaked at $461K in Q1 2026.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.